Boston Scientific (NYSE:BSX) today reported first-quarter financial results that came in ahead of the Wall Street forecast.
Analysts have trimmed their fair value estimate for Boston Scientific from US$100.31 to US$95.75, a reset that anchors the ...
CEO Mike Mahoney told investors that the lowered forecast reflects challenges for several businesses, including ...
On April 22, 2026, investors weigh a rare combo of earnings strength and softer long-term targets reshaping this medtech ...
Despite Boston’s Q1 performance denoting a YoY rise of 11.2%, the company has trimmed its full-year growth outlook by 2% at the top-end.
Boston Scientific (NYSE:BSX | BSX Price Prediction) stock has taken a beating in 2026 after management cut full-year guidance ...
April 22 (Reuters) - Medical device maker Boston Scientific cut its annual profit forecast on Wednesday, overshadowing a ...
In a span of a few years, China has outstripped the U.S. in scientific publications, spending and patents.
AI has already proved itself a valuable scientific tool. Could it take on a more central role in the research process?
Results that may be inaccessible to you are currently showing.
Hide inaccessible results